Making the Bullish Call

Published on
March 15th, 2019
12 minutes

Making the Bullish Call

Trade Ideas ·
Featuring Fahad Khalid

Published on: March 15th, 2019 • Duration: 12 minutes

Fahad Khalid, founder & CIO of JaguarAnalytics, joins Real Vision for the first time to explain how to take advantage of the opportunity in 5G. He discusses the upside potential for shares of Verizon, and reviews an options trade to play the thesis, in this interview with Justine Underhill. Filmed on March 12, 2019.


  • TZ
    Tibor Z.
    15 March 2019 @ 18:24
    Unfortunately 5G will cause cancer. Even 4G has the potential. But the wavelength is so much shorter it puts a lot of stress on the cells. There is a video on YouTube from Melbourne University. Dr. Debra Davis The true about mobile phone and wireless radiation. Shocking! It's a must see!
    • WP
      William P.
      16 March 2019 @ 04:20
      Have you abandoned your cell phone?
    • CR
      Corey R.
      17 March 2019 @ 15:33
      The wavelength of visible light is several orders of magnitude shorter than 4G or 5G. ie If these wavelengths were carcinogenic, you should worry more about the screen than the 5G (luckily they are not). Not sure who Debra Davis is but this sounds like BS
  • TZ
    Tibor Z.
    15 March 2019 @ 18:19
    This is exactly what REALVISION needs. Long term, deep fundamental analysis and stock ideas and a portfolio system. Not just trade ideas. That's the biggest thing I missing from RV! With that RV would be booming like never before!
  • OC
    Otto C.
    15 March 2019 @ 17:32
    VZ's prior high of $69.5 was in 1999 and its still below it so if one has another 20 yrs to waste it might work out. Besides, the chart doesn't look impulsive so I would be shorting VZ at this point. I agree that 5G will be a boom regardless of its health issues but it'll happen on the next bull market, not at the end of this current business cycle.
  • AM
    Artem M.
    15 March 2019 @ 10:43
    Good idea, until they have the shit sued out of them for giving kids cancer.